Avoiding Treatment Interruptions: What Role Do Australian Community Pharmacists Play? by Abukres, Salem Hasn et al.
RESEARCH ARTICLE
Avoiding Treatment Interruptions: What Role
Do Australian Community Pharmacists Play?
Salem Hasn Abukres1, Kreshnik Hoti1,2*, Jeffery David Hughes1
1 School of Pharmacy, Curtin University, Perth, Western Australia, Australia, 2 Faculty of Medicine,




To explore the reported practice of Australian community pharmacists when dealing with
medication supply requests in absence of a valid prescription.
Methods
Self-administered questionnaire was posted to 1490 randomly selected community phar-
macies across all Australian states and territories. This sample was estimated to be a 20%
of all Australian community pharmacies.
Results
Three hundred eighty five pharmacists participated in the study (response rate achieved
was 27.9% (there were 111 undelivered questionnaires). Respondents indicated that they
were more likely to provide medications to regular customers without a valid prescription
compared to non-regular customers (p<0.0001). However, supply was also influenced by
the type of prescription and the medication requested. In the case of type of prescription
(Standard, Authority or Private) this relates to the complexity/probability of obtaining a valid
prescription from the prescriber at a later date (i.e. supply with an anticipated prescription).
Decisions to supply and/or not supply related to medication type were more complex. For
some cases, including medication with potential for abuse, the practice and/or the method
of supply varied significantly according to age and gender of the pharmacist, and pharmacy
location (p<0.05).
Conclusions
Although being a regular customer does not guarantee a supply, results of this study rein-
force the importance for patients having a regular pharmacy, where pharmacists were more
likely to continue medication supply in cases of patients presenting without a valid prescrip-
tion. We would suggest, more flexible legislation should be implemented to allow pharma-
cists to continue supplying of medication when obtaining a prescription is not practical.
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Introduction
Pharmacists in community pharmacies worldwide are often faced with customers requesting
supply of prescription medication without a prescription or without a current valid prescrip-
tion.[1–3] In this paper, ‘invalid prescription’ refers to an out of date prescription or a prescrip-
tion without any remaining repeats. In Australia, except in the case of controlled drugs,
prescriptions are valid for one year from the date of issue, or six months for controlled medica-
tions.[4] When the prescription expires, the patient must see their regular prescriber or any
registered prescriber (e.g. doctor, nurse practitioner) to obtain a new prescription. However,
there are situations when obtaining an appointment with the prescriber is not practical and
this may result in treatment interruption.[5]
When customers run out of their prescription medicines, they may ask their regular phar-
macy (or any other pharmacy) to supply their medication without a valid prescription, based
on their last valid prescription. In this situation in Australia, pharmacists have the right to Not
Supply (NS), or supply using: (a) Owing Prescription (OP) system, or (b) Emergency Supply
(ES) system.[6] In the case of OP, the pharmacist is required to contact the prescriber to
approve the OP supply, if the prescriber is not contactable, the pharmacist must not use this
method. This method is funded nationally through Pharmaceutical Benefits Scheme (PBS).
The PBS is a Government subsidy system for medication costs and professional fees for all Aus-
tralian residents. Therefore, customers supplied with their one repeat of medication through
this system are not charged beyond the usual co-payments. It requires a verbal approval (and a
paper prescription within a week) by the original prescriber, and this may not be practical or
possible in some situations.[5] Therefore, OP is not always available. The second method of
supply (i.e. ES) does not require contact with the original prescriber. However, it only enables
pharmacists to supply a limited amount of the medication and customers are charged a pre-
mium for the cost of medication (i.e. a broken pack fee) and a dispensing fee.[7] Disadvantages
of the above systems have led to a new method of supply in the absence of a valid prescription,
namely Continued Dispensing (CD). CD has been implemented in the majority of Australian
states/territories since September 2013. CD allows the dispensing of one standard pack of the
medication. However, it is currently only allowable for statin and oral contraceptive users.[5]
An expanded version has been supported by its eligible users (i.e. statins and oral contraceptive
users),[8] and health organizations such as the Pharmaceutical Society of Australia.[9] It is
worth mentioning that at the time of conducting the present study, CD was either not imple-
mented (i.e. time of initial survey), or had just implemented (i.e. for less than one month at the
time of reminders). Therefore, this study collected information about community pharmacists’
practice before (or just shortly after) CD implementation.
Several factors may influence the method that pharmacists use to deal with medication
requests without a valid prescription.[10] Firstly, the type of prescription. In Australia there are
three types of prescriptions (according to what medications can be prescribed, number of
repeats and funding): Standard PBS Prescriptions (Standard), PBS Authority Prescriptions
(Authority) and Private Prescriptions. The PBS contains a list of medications (dispensed at a
Government-subsidized price) which may be prescribed using Standard Prescriptions or
Authority Prescriptions. Standard Prescriptions are the most commonly used for medications
on the PBS list because they do not require a third party authorization. However, the prescriber
must abide by the prescribing conditions such as the indication of use and number of repeats
for individual Standard PBS items.[11] Authority Prescriptions are used to prescribe PBS listed
medications which have restricted supply conditions (e.g. for a particular indication) or are
prescribed in greater quantities or with more repeats than usually available through the PBS.
For both prescription types, patients’ co-payments range from AU $6.10 to AU $37.70
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depending on their status of concession. The rest of the medications’ costs and pharmacists’
fees are paid by the PBS.[12] Private Prescriptions are generally used to prescribe medication
not listed in the PBS and/or when supply is not eligible under the PBS rules, in this case
patients pay the full cost of the drug and supply.[6] Printed Standard and Authority Prescrip-
tions are required to enable pharmacists to claim reimbursement from the PBS system, The
administrative complexity to obtain a new prescription (particularly Authority Prescriptions)
to cover medication supply without a valid prescription varies according to prescription type.
[7] Consequently, pharmacists are likely to take this factor into their consideration in their
decision to supply, and if so using what method of supply.
Secondly, customer type may also influence the method that pharmacists choose in dealing
with a medication request in the absence of a valid prescription. Since pharmacies keep records
of medication supply for each customer, pharmacists can review the customer’s medication
dispensing history.[13] In addition, pharmacists may establish a relationship with their regular
customers.[5,14] Therefore, pharmacists may provide different (and potentially more prefera-
ble) options for regular compared to non-regular customers.[2] For example supply rather
than refusal to supply, or supply with OP rather than ES.
Thirdly, the type of the medication. This factor may have a positive or negative impact on
pharmacist‘s decision.[2] For example, requesting an antihypertensive medication is entirely
different from seeking a benzodiazepine without a valid prescription. While the motivation for
requesting an antihypertensive is likely to be solely for medical reasons, the request for the ben-
zodiazepine may not always be medically motivated.[15]
Fourthly, the frequency of request may also affect pharmacists’ decisions.[2] For example, if
the customer repeatedly requested the same medication under the guise that they were unable
to see their regular prescriber, this would probably reduce the likelihood that the pharmacist
would provide an additional supply. However, without a fully implemented electronic health
record, pharmacists may not be able to identify if a previous supply without a valid prescription
was made in another pharmacy.
Finally, pharmacists’ decisions may differ according to their demographic status. Previous
studies have shown that pharmacists had different practices according to their age, gender and
pharmacy location.[16–18] Therefore, these factors may affected pharmacists’ decisions to sup-
ply or refuse to supply medications without a valid prescription.
This study investigated: (a) the frequency of requests by different customer types, (b) how
would Australian pharmacists deal (supply or not supply and which method of supply they
use) if they faced with hypothetical scenarios of customers requesting medications without a
valid prescription) and (c) factors which influence their decisions.
Methods
Australia has six states and two territories. They can be arranged according to percent of regis-
tered pharmacists as New South Wales (NSW) (31%), Queensland (QLD) (26%), Victoria
(VIC) (20%), Western Australia (WA) (11%), South Australia (SA) (7%), Tasmania (TAS)
(3%), Australian Capital Territory (ACT) (2%), and Northern Territory (NT) (1%). A self-
administered questionnaire was sent to a randomly selected sample of community pharmacies
in Australia. All pharmacies in each Australian state or territory (on the Yellow Pages website)
were entered into an ExcelTM file, and then a random sample (20% of pharmacies) was selected
using a simple random technique. A 20% sample was chosen as it allows a representative sam-
ple to be drawn from a large number of potential respondents. Therefore, 1490 questionnaires
were distributed with an anticipated response rate of approximately 40% (it was anticipated to
lead to approximately 600 responses, with 95% confidence level with +/-2.5 confidence
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interval). The randomization was done by using an electronic randomizer (http://www.
randomizer.org/). The Yellow Pages website was the only readily available source to obtain
postal and email addresses of Australian pharmacies. Efforts were made to obtain these
addresses from licensing bodies, however, these attempts did not succeed. Sample selection
depended on the number of pharmacies in each state/ territory. A total of 1490 pharmacies
were selected: 464 from NSW, 378 from VIC, 326 from QLD, 135 fromWA, 120 from SA, 39
from TAS, 16 from ACT and 12 from NT. The questionnaire was sent during late August 2013
by post. Whilst postal and email reminders (173 emails, i.e. those where email addresses were
available) were sent out a month later (i.e. before and after implementation of the CD system
in most Australian States).[19] Therefore, the questionnaire did not contain the option CD as a
potential method of supply. In other words, the questionnaire explored the pharmacists’
reported practice before CD became an additional option of supply. The questionnaire did not
collect information about pharmacies characteristics, such as the number of employees, the
number of prescriptions dispensed or ownership of pharmacy. The postal survey was chosen
because it is a cost-effective method to contact a relatively large number of pharmacies in Aus-
tralia given its geographical size.[20] Participants were considered consented if they returned
the questionnaire. No incentives were provided for participation.
Questionnaire Design
Results of a literature review and experience from previous studies were used in the develop-
ment of the questionnaire.[5,20] The questionnaire’s face and content validity were assessed
for by piloting it with five pharmacists and eight pharmacy academic staff members working in
the area of pharmacy practice at School of Pharmacy, Curtin University. After incorporation of
the suggested changes, such as deletion of some questions (because they were deemed irrele-
vant), the final questionnaire contained 19 questions. In this manuscript, we report only five
questions that cover two areas; (a) frequency of medication requests without a valid prescrip-
tion by regular and non-regular customers, and (b) the reported practice by pharmacists when
dealing with such requests. In addition to these areas, we also report participants’demographic
information (age, gender of the participant and pharmacy location; urban
(population> 100,000) or rural (population< 100,000).[21] A regular customer was defined
as a customer who attended the pharmacy five times or more in the past 12 months, while the a
non-regular customer was defined as a customer who: attended the pharmacy fewer than five
times in the past 12 months. These definitions were obtained from the Australian Health
Department website and were provided within the questionnaire.[22] The first question sought
information about the frequency of customers (regular and non-regular) requesting medica-
tion(s) without a valid prescription. The second question looked at what the participants
would do (NS, OP, ES or Other) when facing a medication request without a valid prescription.
Therefore, they were asked to report what they would normally do when dealing with a request
for each of the 19 different medication classes (See S1 Appendix). In this case the request was
made by a regular customer with a stable chronic disease (as judged by the participant after
consultation with the customer) and based on a previous supply with: a) Standard Prescription,
b) Authority Prescription, or c) Private Prescription. Therefore, three different scenarios were
used. We assumed that the pharmacist would not supply when it was not safe to do, would try
to contact the original prescriber to supply using OP, or dispense a limited quantity of the
requested medication using ES if the communication with the prescriber was not possible (they
could also use the “Other” option to report their other actions). The third question was about
the reported practice if the same customer requested the same medication (regardless the pre-
scription and medication types) for a second time without seeing the prescriber. The fourth
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question was the same as the second, whilst the fifth was the same as the third, but both dealt
with non-regular customers. Questions 3 and 5 were used to explore only the effect of the fre-
quency of request and customer type on participants’practice. Therefore they were shortened
to include only these factors. This has the advantage of decreasing the time needed to answer
the questionnaire (which contained a total of 19 questions), without changing the intended
meaning and purpose of the questions. Yet, Questions 3 and 5 provided valuable data particu-
larly comparing participants’reported practice with regular and non-regular customers. Fur-
ther details of the questionnaire are provided in the S1 Appendix (abridged version).
Ethical Approval
This study was approved by The Human Research Ethics Committee of Curtin University
(Approval number: PH-07-13).
Data Analysis
Answers to each question were analyzed using SPSS1 version 22 (http://www-01.ibm.com/
software/au/analytics/spss/). Responses to questions were entered into an ExcelTM file (See S1
Dataset), and then transferred to an SPSS1 data file. SPSS1 was used to summarize data and
produce frequency tables and to describe the reported practice according to customer, prescrip-
tion and medication types. Since the same participant was asked twice (i.e. first, would they
supply or refuse to supply for regular customers, and second for non-regular customers) the
McNemar test was used to compare the supply practices of medications between regular and
non-regular customers. This test was initially utilized through the Transformed Process in the
SPSS1 to convert responses into the dichotomous responses of Not Supply (NS) and Supply
which included ES, OP and ES&OP responses. Multinomial regression was used to investigate
the effect of demographic variables: age, gender, and pharmacy location description (urban or
rural) on participants’ decisions to supply and what method of supply they used (i.e. ES or
OP). Participants were compared according to: age for the purpose of analysis this variable was
re-grouped into two groups only (the younger group i.e. 40 years vs the older group>40
years of age), gender (male vs female), and pharmacy location (urban vs rural). For all tests a p
value of 0.05 was taken to indicate a statistically significant association. Multinomial regres-
sion was used because it is appropriate to model a 3-level categorical outcome variable.[23]
According to Tabachnick and Fidell, “regression analysis with over approximately 150
responses are adequate to identify independent variables which exhibit a moderate effect
size.”[23] It does not require a large sample and 10 cases in each variables are considered suffi-
cient.[24] Finally, Mann-Whitney test was used to detected differences between those who
responded to the initial questionnaire and those who responded to the reminder. This test was
used because it is appropriate to compare two independent samples.
Results
Response Rate
The total questionnaires received were 385 and there were 111 undelivered questionnaires.
There were 268 responses from the first mail-out and 117 from the reminder (including six via
email). There were only 63 responses from the states were CD was actually implemented. No
statistically significant differences (Mann-Whitney test) were detected between those who
responded to the initial questionnaire and those who responded to the reminder. The overall
response rate was 27.9% of delivered questionnaires. Response rates from states and territories
ranged from 0% in Northern Territory to 51.4% in Tasmania.
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Demographic Data
Males were the dominant gender group of the respondents. According to age, the respondents
were almost equally divided into two groups (40 years old and> 40 years old). The distribu-
tion of the respondents within states/territories corresponded to the number of pharmacies
(hence the sample selected) in each state/territory. The participants’ primary place of work was
community pharmacy (96.6%). Our demographic data is comparable to data published in a
report by Health Workforce Australia 2014.[25] Further demographic details and national fig-
ures are shown in Table 1.
Weekly Requests
The participants were asked to estimate the number of medication requests without a valid pre-
scription that pharmacy received from regular and non-regular customers on a weekly basis.
Four options were offered to participants to select; zero, one or two, three to four, and five or
more. The most reported number of requests per week was five or more made by regular cus-
tomers reported by 66.8% (n = 257) of the participants, followed by three to four times reported
by 19.5% (n = 75) and one or two times reported by 8.6% (n = 33), while only 2.9% (n = 11)
reported that they did not face such requests from regular customers and nine participants did
not answer this question. Interestingly, one participant reported the number of requests from
regular customers as 50 per week. In the case of non-regular customers, one or two requests
per week was the most frequent, reported by 48.3% (n = 186) of the participants followed by
Table 1. Demographic characteristic of the participants (n = 385).
Variable Categories Survey Data n (%) Australian Data# n (%)
Gender Male 210 (54.5) 8,916 (41.8)
Female 155 (40.3) 12,415 (58.2)
Prefer not to disclose 20 (5.2) *NA
Age (years) 20–30 90 (23.4) *NA
31–40 98 (25.5) *NA
41–50 83 (21.6) *NA
51–60 83 (21.6) *NA
> 61 26 (1.8) *NA
Prefer not to disclose 5 (1.3) *NA
State or Territory ACT (Australian Capital Territory) 5 (1.3) 373 (1.7)
QLD (Queensland) 92 (23.9) 4,197 (20.0)
NSW (New South Wales) 90 (23.4) 6,584 (31.0)
NT (Northern Territory) 0 (0) 157 (0.07)
SA (South Australia) 31 (8.1) 1,625 (7.6)
TAS (Tasmania) 18 (4.7) 554 (2.6)
VIC (Victoria) 92 (23.9) 5,465 (25.6)
WA (Western Australia) 54 (14.0) 2,367 (11.0)
Prefer not to disclose 3 (0.8) *NA
Pharmacy location Urban (Metropolitan) 279 (72.5) 16,225 (76.0)
Rural (rural, remote and other) 100 (26.0) 5,088 (24.0)
Prefer not to disclose 6 (1.6) *NA
# Source: Health Workforce Australia 2014,[22] according to this source the total number of pharmacists in 2012 was 21,331 working in different
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five or more, reported by 21.3% (n = 82), three to four times reported by 10.1% (n = 39), and
zero times was reported by 9.4% (n = 36). There were 42 participants who did not answer this
question.
The Reported Practice
The participants were asked about what they would do (Not Supply [NS], Owing Prescription
[OP], Emergency Supply [ES] or Other) when dealing with hypothetical scenarios of a patient
with a stable chronic disease requesting listed medications without a valid prescription, if this
request was based on a previous supply with either a Standard, Authority, or Private Prescrip-
tion, and was made by: (A) a regular customer or (B) an non-regular customer. The frequency
of supply and the reported practice differed according to prescription, customer and medica-
tion type as outlined below.
1. Total Supply. Fig 1 displays the overall supply according to customer, prescription and
medication types. Results are summarized below.
a. According to customer type: Regardless of prescription or medication type, for all listed
medications the likelihood of supply for regular customers was greater than for non-regular
customers (Fig 1). The McNemar test was used to compare the NS and supply for each medi-
cation as dichotomous dependent variables between the two customer types as dichotomous
independent variables. In all cases the difference was statistically significant (p < 0.0001),
suggesting a higher rate of supply for regular customers in comparison to non-regular
customers.
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b. According to prescription type: The lowest rate of supply was for Authority Prescrip-
tions, irrespective of customer or medication type. The highest rate of supply was associated
with Standard Prescriptions (for regular customers) or Private Prescriptions (for non-regular
customers), depending on medication type (Fig 1).
The McNemar test revealed statistically significant differences between the supply (or not
supply), based on Authority Prescriptions and the other prescription types, for all medication
types (p value< 0.05) and for each customer type. However, in a few cases there were only sig-
nificant differences between Standard and Private Prescriptions (See Fig 1 for more details).
Note in the case of psoriasis medication (and similar cases) for regular customers, the percent-
ages of participants who decided to supply in both prescription types were identical (i.e.
68.3%), in these cases the significant differences arose from the differences in the numbers of
participants who did not supply. For example, in the case of psoriasis medication for regular
customers, there were 111 participants who selected NS in the case of Standard Prescription
and 85 participants in the case of Private Prescriptions.
c. According to medication type: All listed medications, except opioids, were supplied by
over 50% of participants regardless of prescription type, if the request for supply was made by a
regular customer. If the request was made by a non-regular customer, there were more medica-
tions that would not be supplied by pharmacists in the case of Standard or Private Prescriptions
(Fig 1). However, if the prescription was an Authority Prescription, the majority of the partici-
pants would not supply the listed medications.
2. The reported practice.
a. Regular customers: The most reported method of medication supply was OP (Fig 2) in
the case of either Standard or Private Prescriptions, except in the case of chronic pain non-
Fig 2. Method of supply (%) for regular and regular customers according to prescription andmedication types.
doi:10.1371/journal.pone.0154992.g002
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opioids, antianxiety medications and opioids. In the case of Authority Prescriptions, if partici-
pants provided medications they used ES more frequently than OP; however there was a
greater level of NS compared to Standard and Private Prescriptions.
b. Non-regular customers: In the case of non-regular customers, there was a greater inci-
dence of NS for all prescription types, and for all types of medication. In the case of supply, the
preferred method of supply was ES. In contrast to regular customers, the frequency of OP use
was more for Private Prescriptions than Standard Prescriptions (See Fig 2 for more details).
Frequency of Request
The reported practice was NS for both types of customers in cases where a second consecutive
request was made before the patient obtained a new prescription. However, the likelihood of
obtaining the medication was higher for regular than non-regular customers (26.3% [19.0% ES
+ 7.3% OP] vs 6.3% [5.5% ES + 0.8% OP], p< 0.0001).
Effect of Some Variables on the Reported Practice
Multinomial regression analysis revealed that participants’ demographic variables (age, gender
of participants and pharmacy location) had significant effects on the reported practice of how
participants dealt with medication supply requests. In general and depending on the prescrip-
tion and customer type, older participants were more likely than the younger participants to
supply the following medications: antianxiety, non-opioids and opioids. Younger participants,
however, were more likely to provide antidepressants, psoriasis medications, statins and non-
statins. Participants who worked in urban areas were more likely to supply antianxiety, arthritis
and Gastro-Esophageal Reflux Disease (GERD) medications than participants worked in rural
areas, while male pharmacists were more likely to supply opioids than female pharmacists
(Table 2).
Alternative Model for Medication Supply
A small number of participants (ranged from 0 to 0.08%) reported they used a hybrid model of
ES and OP. In this case, the customer is provided with the minimum applicable quantity of the
medication (three day’s supply or the full pack [e.g. for an inhaler medication]) and required to
pay the full cost (i.e. ES) and then when the customer presents a new valid prescription they
are provided with the remaining quantity and either pay or are refunded any difference
between ES and PBS co-payments (i.e. OP).
Discussion
To our knowledge, this is the first study to explore thereported practice of Australian commu-
nity pharmacists when dealing with medication requests in the absence of a valid prescription.
Such requests have also been reported in the international literature.[26,27] Worldwide there
have been a number of changes in legislation to allow pharmacists to supply medication in
urgent situations. For example, in some Canadaian Provinces, pharmacists may legally adjust
the medication dose, or change the dosage form of prescribed medications to ensure treatment
continauion when access to the original prescriber is not practical.[27]
Results of the current study showed that Australian community pharmacists face such
requests on a weekly, if not daily, basis. Inability of customers to obtain same-day appoint-
ments was reported as a cause in both the Australian and international literature.[28,29] In a
recently published Australian study, Garth et al. reported that not all patients requesting same
day appointments would be able to be seen by their doctor.[28] In regards to medication
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requests without a valid prescription, regular customers were more likely to make such requests
compared to non-regular customers (5 or more vs. 1–2 times per a week). In a previous study,
requesting medication without a valid prescription was also reported by approximately one-
third of patients who ran out of their medication.[5] In a recently published study from the
UK, Morecroft et al. reported that requests for urgent medication supply were more likely
around weekends and when other services were not available.[2] In the current study, where
possible and appropriate, community pharmacists assist customers by providing an ongoing
supply until they can see their doctor. They are more likely to provide ongoing supply if the
medication requested is not for a drug with abuse potential, the customer is a regular and the
prescription is either a Standard or Private Prescription, where obtaining a new prescription is
less difficult than Authority Prescriptions. The reported practice of pharmacists dealing with
medication requests in the absence of a valid prescription emphasizes the importance of cus-
tomers having a regular pharmacy.[10]
Results of this study indicated that there were substantially different practices by pharma-
cists when dealing with hypothetical scenarios of medication requests without a valid prescrip-
tion according to the customer, prescription, medication types, and frequency of the request.
There were a number of factors associated with lower rates of medication supply and more
usage of the ES or NS as the most reported practices. These factors included (1) non-regular
Table 2. Effects of demographic variables on participants’ decisions to supply (n = 385).
Customer type Medication Prescription type More likely to Supply Group P value
Regular Antianxiety Standard Older (>40 years) 0.008
Antianxiety Authority Urban 0.044
Antianxiety Private Older (>40 years) 0.022
Antidepressants Standard Younger  40 years) 0.033
Antidepressants Authority Younger ( 40 years) 0.005
Antidepressants Private Younger ( 40 years) 0.023
Non-opioids Standard Older (>40 years) 0.006
Non-opioids Authority Older (>40 years) 0.023
Non-opioids Private Older (>40 years) 0.022
Statins Standard Younger ( 40 years) 0.007
Statins Authority Younger ( 40 years) 0.015
Statins Private Younger ( 40 years) 0.022
Arthritis Standard Urban 0.016
Arthritis Authority Urban 0.003
Arthritis Private Rural 0.028
Opioids Authority Older (>40 years) 0.03
Opioids Private Male 0.027
Psoriasis Standard Male 0.008
Psoriasis Private Female 0.012
Psoriasis Private Younger ( 40 years) 0.028
Anticoagulants Authority Female 0.028
GERD Private Urban 0.003
Non-regular Statins Standard Younger ( 40 years) 0.03
Statins Private Younger ( 40 years) 0.048
Non-statins Standard Younger ( 40 years) 0.046
GERD: Gastro-Esophageal Reflux Disease
doi:10.1371/journal.pone.0154992.t002
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customer (probably due to lack of dispensing history), (2) Authority Prescription (this seems a
result of potential difficulties in obtaining a new valid prescription, which might result in
breach of legal requirements and/or financial loss), and (3) medication type, in particular
chronic pain non-opioids, antianxiety medications and opioids (probably because of abuse
potential). Indeed, as these factors augmented, the medication supply became less frequent,
resulting in more NS decisions. While the NS decision is recommended to deal with medica-
tions with abuse potential, pharmacists may find themselves in complex situations with legiti-
mate requests for medical purposes such as patients with cancer.[15]
The ES method was the most commonly reported method of supply, in cases of the presence
of one or more of the above factors, presumably because ES does not require contact with the
prescriber or a future prescription. However, it is a costly method for the customer and allows
only a three days’ supply. As a result of the cost,[30,31] customers may refuse to obtain their
medications through ES.[15,19] Consequently, non-regular customers had a significantly
lower overall rate of supply than regular customers (p< 0.0001). This is consistent with a pre-
vious study, where non-regular customers reported they ran out of their medications more fre-
quently than regular customers.[5] The main reason related to these factors may be a potential
lack of trust as reported by Hoti et al. in the pharmacist prescribing context.[32] Pharmacists
may not feel confident to supply to customers for whom they do not know their medication
supply history, do not trust them to accurately report their health issues and/or bring a new
valid prescription back to the pharmacy, particularly in the case of Authority Prescriptions
which require a third party approval.
The OP method was the most commonly reported method of supply for requests made by
regular customers, based on a previous supply with a Standard or Private Prescription, and
when the medication was not a chronic pain non-opioid, antianxiety medication or opioid. It is
not clear whether participants used the ‘Standard OP’ procedure (i.e. supply only after the
pharmacist communicated with the prescriber) or the “in advance” OP which is conducted
without such communication.[5] ‘In advance’ OP is not strictly a legal method of supply; how-
ever it is used when the pharmacist is satisfied a regular customer will bring a valid prescription
following their next visit to the prescriber. This is similar to ‘loan’ supply in the UK, which is
used to supply medication for urgent requests without a prescription but with a future pre-
scription anticipation. Morecroft et al. reported that avoiding additional cost to customers was
one of the motivations for pharmacists’ use of this method.[2] We assume that pharmacists
will firstly try to contact the prescriber and if that is not possible (thus the Standard OP is not
applicable) then they may refuse to supply, use ES, or use the ‘in advance’OP method of sup-
ply. In the case of non-regular customers, OP was less frequently used (ranged from 2.1 to
20%). This may reflect difficulty to communicate with the original prescriber of non-regular
customers.
Frequency of requests also affected pharmacist’s decisions. If the same patient requested a
second consecutive supply because of continued inability to see their regular prescriber the
most reported practice was NS. Although participants were more flexible with their regular
customers, through providing them an ES supply, compared with non-regular customers for
whom the possibility to obtain a second supply was very small (p<0.0001). This may answer
the question from a previous research project about “at what point does the pharmacist say,
“We will no longer supply until you see the doctor?”[7] This indicates that pharmacists do not
endlessly supply medication without a valid prescription and at the same time they appreciate
patients’ difficulty in seeing their regular prescribers. In a previous study repeated requests was
also reported as a source of distress for pharmacists, particularly if they perceived them as sys-
tem abuse by patients to avoid medical review, which they have to pay for or take time off work
to have done.[2]
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Some demographic variables affected pharmacists’ reported practice. This effect of demo-
graphic variables is consistent with previous studies which demonstrated the association
between pharmacists’ demographics and their decision making process and/ or their attitudes
towards patients.[16–18] Older, males and/or pharmacists working in rural areas were more
likely (than their younger, female and/or urban counterparts) to supply chronic pain non-opi-
oids, antianxiety medications and opioids. This may have resulted from the experience of the
pharmacist, where male pharmacists tended to be older than females (p< 0.05), working more
on a full time basis and probably they were more likely to be a pharmacy owner.[25] Thus they
may have had longer relationships with their customers and their customers’ doctors. There-
fore, they may be more confident that they would obtain the anticipated prescription and/or as
owners they were more able to take the financial risk of supplying medication without prescrip-
tion if the anticipated prescription could not obtained. Furthermore, pharmacists working in
rural areas may have had more regular customers (as result of fewer pharmacies in rural areas)
and/or longer relationships (due to nature of living in rural areas) with their customers than
their counterparts in urban areas.[33]
An alternative method to supply medications was also reported. As far as we know, this
method has not been reported in the Australian literature before. It is a combination of both ES
and OP methods. This seems to be a practical way to satisfy the customers’ needs for urgent
medication supply without strictly breaking the rules, as well as avoiding any financial loss if
the anticipated prescription is not obtained. Several steps have been taken by the pharmacy
regulatory bodies to improve access to medication when it is impractical to obtain a renewed
prescription, such CD. However, this method is restricted in terms of its frequency and its eligi-
ble medications.
Even though the sample of pharmacists was consistent with the number of pharmacies in
each state/ territory the low response rate was the main limitation of this study, which is consis-
tent with the difficulty of obtaining high response rates from healthcare professionals in gen-
eral, including pharmacists.[34,35] In addition, there were a number of undelivered
questionnaires which may have resulted from outdated addresses on the Yellow Pages website.
Access to a more accurate mailing list and greater access to email addresses may have enhanced
the response rate. The fact that there were 63 responses from states where CD had been imple-
mented could be seen as a confounding factor. However, there were no statistically significant
differences between those who responded to the first mail out and those who responded after
the reminder (which was returned less than one month after CD became an available option).
Moreover, CD uptake by pharmacists was reported to be very low in the first 10 months of its
implementation.[19] No measures were made to identify who participated and who did not,
whilst this makes a comparison between respondents and non-respondents not possible, it has
the advantage of collecting more truthful data that reflects the actual behaviors of the respon-
dents.[36] There were a large number of pairwise comparisons undertaken, which suggested
the existence of a number of significant associations. Because use of the Bonferroni adjustment
is not appropriate in this setting (inappropriate null hypothesis), we acknowledge that some p-
values may have been less than 0.05 by chance alone (type I error). Furthermore, for statistical
purposes, we compared participants according to their age as a dichotomous variable, hence
decreasing error probability, however, age may not be a valid indicator of pharmacist experi-
ence. Finally, results of this study are based on reported behaviors to hypothetical scenarios
rather than observation of real practice. Consequently, although the fact that the majority of
participants of this study faced similar requests in their practice, minimizes the possibility of
natural variance between the reports and reality, there is still a possibility that participants may
deal differently with actual customers in real practice (i.e. they may have been self-reporting
their ideal behaviors rather than their actual practice). Factors which contribute to the
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strengths of present study include: being the first to explore this area in such detailed way, the
sample was selected from all Australian states and territories, and the use of hypothetical sce-
narios method has been proved to be effective and inexpensive tool to reflect the actual practice
by healthcare professionals (doctors) with high content and face validity.[37] Moreover, anon-
ymous reporting by study participants would eliminate “Hawthorne effect” (i.e. participants
enhancing their actions under surveillance) that may occur during direct observation studies.
[38] According to Evans et al.[39] case vignettes are appropriate to approximate, isolate,
manipulate, and measure key aspects of the decision-making processes that individuals use in
real world situations, and when “. . .well designed to test specific questions about judgments
and decision-making, they can be highly generalizable to ‘real life’ behavior, while overcoming
the ethical, practical, and scientific limitations associated with alternative methods (e.g. obser-
vation, self-report, standardized patients, archival analysis).”[39] Finally, although study gener-
alizability may be negatively affected by the low response rate, our sample successfully reflected
the national figures regarding pharmacists’ demographic information, which supports study
representativeness. This study is likely to prompt further investigations of the issues raised by
its findings.
Future studies should focus on exploring the use of technology in enhancing the probability
of obtaining a medication supply without a valid prescription in cases where contacting the
original prescriber is not practical. It should also explore ways to improve communication
between healthcare professionals with the view of minimizing requests for medication in the
absence of valid prescriptions.
Conclusions
Results of the current study showed that pharmacists face requests for medications without a
valid prescriptions on a weekly, if not daily basis from both regular and non-regular customers.
Our results emphasize the importance of patients having a regular pharmacy to minimize med-
ication interruption when obtaining a new prescription for a chronic medication is not practi-
cal. In advance arrangement to obtain a new prescription is highly recommended to avoid such
interruptions, particularly for medications with the potential for abuse and for medication that
requires authorization prior to prescribing. Moreover, models of allowing pharmacists to sup-
ply without a valid prescription, when it is safe to do, should be explored and implemented
especially given that being a regular customer of a pharmacy does not guarantee supply. Future
research should investigate reasons for medication requests without a valid prescription, why
they are so frequent and what impact might these reasons have on pharmacists’ decisions, par-
ticularly taking into account the work by Morecroft et al. who highlighted that a perception of
a “genuine mistake” can occur in different responses to a deliberate choice to try to deviate
from standard practice.[2] Further, timely and cost-effective ways of communication between
healthcare professionals, accessible electronic health records and/or pharmacists prescribing
rights as other means of minimizing treatment interruptions resulting from the absence of
valid prescriptions.
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